NEW YORK, April 13, 2011 /PRNewswire/ -- 5W Public Relations, one of the 25 largest PR Agencies in the U.S., today announced the addition of Cold-EEZE to its diverse roster of consumer clients. Cold-EEZE is clinically proven to reduce the duration and symptoms of the common cold including cough, stuffy nose, sore throat, sneezing, post-nasal drip and hoarseness.
"5WPR is extremely excited to be named PR Agency of Record for Cold-EEZE," said Ronn Torossian, CEO of 5W Public Relations. "We have seen tremendous growth in our consumer wellness division in the last few years and look forward to creating added awareness and excitement to the Cold-EEZE brand."
Cold-EEZE is the No. 1 pharmacist-recommended zinc cold remedy and the proprietary (zinc gluconate) formula is believed by researchers to interfere with the cold virus' ability to reproduce. Cold-EEZE uses natural flavors and has no preservatives or colors. It is non-drowsy, non-agitating and does not affect blood pressure. It actually shortens your cold to help you get well sooner.
5W Public Relations will execute a comprehensive integrated public relations program to promote Cold-EEZE in the consumer marketplace. Key elements will include media relations, celebrity integrations, co-branded partnerships, special events and more.
ABOUT 5W PUBLIC RELATIONS
5W Public Relations (www.5wpr.com) is a full-service public relations agency known for implementing cutting-edge, customized campaigns designed to drive our clients' business goals and objectives. 5WPR was founded by Ronn Torossian in 2003, and the energetic and focused culture earned the PR firm a spot on the INC. 500 list and recognition as the nation's "fastest-growing PR agency" three years in a row. Our 24/7 approach led the industry's foremost trade magazine to describe 5WPR as "aggressive in a way that clearly resonates with clients looking for a firm staffed with Type A-plus personalities, a BS-free approach, and results from Day One."
About ProPhase Labs
ProPhase Labs (NASDAQ: PRPH) is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA approved facility to manufacture Cold-EEZE lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories, LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. The joint venture plans to formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels. For more information, visit www.ProPhaseLabs.com.
CONTACT: Ronn Torossian, +1-212-999-5585, [email protected]
SOURCE 5W Public Relations